Skip to content
DraconiticResearch
Search Sources API
197,688 studies31 sourcesUpdated 28 min ago
Peer-reviewedCC BYHematology, transfusion and cell therapy

Tumor glycosylation and ABO phenotyping alterations in invasive urothelial carcinoma: A case report.

  • Vanessa Cristina Fanger1
  • Isabelle Carolina Cotrim Gozzi2
  • Marina Cavalcanti de Albuquerque da Veiga Conrado3
  • Regina Aparecida Cardoso3
  • Vanderson Rocha4
  • Alfredo Mendrone-Junior3
  • Carla Luana Dinardo3
4 affiliations
  1. 1Fundação Pró-Sangue, Hemocentro de São Paulo, São Paulo, SP, Brazil. Electronic address: [email protected].
  2. 2Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brazil.
  3. 3Fundação Pró-Sangue, Hemocentro de São Paulo, São Paulo, SP, Brazil.
  4. 4Fundação Pró-Sangue, Hemocentro de São Paulo, São Paulo, SP, Brazil; Fundação Faculdade de Medicina da Universidade de São Paulo (FFMUSP), São Paulo, SP, Brazil.
Read full textPDFDOICite

Related

  1. Impact of neoadjuvant chemotherapy on the association between key genetic alterations and tumor microenvironment in upper tract urothelial carcinoma
    Daiki Ikarashi, Kenta Takahashi, Shigehisa Kitano +9
    Cancer Immunology, Immunotherapy : CIIPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  2. Efficacy and safety of first- versus second-generation fibroblast growth factor receptor (FGFR) inhibitors in advanced or metastatic urothelial carcinoma with FGFR alterations: a systematic review and meta-analysis
    Zhe Wang, Bo Shao, Danxue Huang +1
    Frontiers in pharmacologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCCrossref
  3. Research progress and clinical translation prospects of multiple urinary biomarkers in non-invasive diagnosis of urothelial carcinoma
    Shuxin Li, Lei Wang, Baoshan Gao
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMC
  4. Oncological Outcomes and Safety Profiles of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma.
    Satoshi Katayama, Tatsushi Kawada, Keiichiro Mori +17
    International journal of urology : official journal of the Japanese Urological AssociationPeer-reviewedCC BYFull text1 citedSurgery & anaesthesiaEurope PMC
  5. Hybrid grading systems improve progression risk stratification in non‐invasive papillary urothelial carcinoma and support a histomorphological continuum of disease progression
    Jane K Nguyen, Marcello P Toscano, Jianbo Li +14
    HistopathologyPeer-reviewedCC BY 4.0Full text1 citedSurgery & anaesthesiaPMC

Cite

BibTeXRIS
BibTeX
@article{fanger2026tumor,
  title = {{Tumor glycosylation and ABO phenotyping alterations in invasive urothelial carcinoma: A case report.}},
  author = {Vanessa Cristina Fanger and Isabelle Carolina Cotrim Gozzi and Marina Cavalcanti de Albuquerque da Veiga Conrado and Regina Aparecida Cardoso and Vanderson Rocha and Alfredo Mendrone-Junior and Carla Luana Dinardo},
  journal = {Hematology, transfusion and cell therapy},
  year = {2026},
  month = oct,
  doi = {10.1016/j.htct.2026.108548},
  url = {https://europepmc.org/article/MED/42854286},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Tumor glycosylation and ABO phenotyping alterations in invasive urothelial carcinoma: A case report.
AU  - Vanessa Cristina Fanger
AU  - Isabelle Carolina Cotrim Gozzi
AU  - Marina Cavalcanti de Albuquerque da Veiga Conrado
AU  - Regina Aparecida Cardoso
AU  - Vanderson Rocha
AU  - Alfredo Mendrone-Junior
AU  - Carla Luana Dinardo
PY  - 2026
DA  - 2026/10/09
JO  - Hematology, transfusion and cell therapy
DO  - 10.1016/j.htct.2026.108548
UR  - https://europepmc.org/article/MED/42854286
SN  - 2531-1379
SN  - 2531-1387
ER  -